Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance

Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance

Sha Zhang,1 Liang Yan,1 Can Cui,2 Zhen Wang,1 Jianhui Wu,1 Ang Lv,1 Min Zhao,3 Bin Dong,4 Wenlong Zhang,5 Xiaoya Guan,1 Xiuyun Tian,1 Chunyi Hao1 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking Unive...

Full description

Bibliographic Details
Main Authors: Zhang S, Yan L, Cui C, Wang Z, Wu J, Lv A, Zhao M, Dong B, Zhang W, Guan X, Tian X, Hao C
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:OncoTargets and Therapy
Subjects:
retroperitoneal liposarcoma
ribonucleotide reductase small subunit m2
tumor progression
akt/mtor/4ebp1 pathway
Online Access:https://www.dovepress.com/downregulation-of-rrm2-attenuates-retroperitoneal-liposarcoma-progress-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/downregulation-of-rrm2-attenuates-retroperitoneal-liposarcoma-progress-peer-reviewed-article-OTT

Similar Items